Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PDK1 inhibitors(3-phosphoinositide-dependent protein kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | United States | 01 Dec 2015 | |
Solid tumor | Preclinical | United States | 01 Dec 2015 |